Chesney M - Search Results

1

Helping the urban poor stay with antiretroviral HIV drug therapy.

Bamberger JD, Unick J, Klein P, Fraser M, Chesney M, Katz MH. Bamberger JD, et al. Among authors: chesney m. Am J Public Health. 2000 May;90(5):699-701. doi: 10.2105/ajph.90.5.699. Am J Public Health. 2000. PMID: 10800416 Free PMC article.

2

Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior.

Martin JN, Roland ME, Neilands TB, Krone MR, Bamberger JD, Kohn RP, Chesney MA, Franses K, Kahn JO, Coates TJ, Katz MH. Martin JN, et al. AIDS. 2004 Mar 26;18(5):787-92. doi: 10.1097/00002030-200403260-00010. AIDS. 2004. PMID: 15075514 Clinical Trial.

3

Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure.

Roland ME, Martin JN, Grant RM, Hellmann NS, Bamberger JD, Katz MH, Chesney M, Franses K, Coates TJ, Kahn JO. Roland ME, et al. Among authors: chesney m. J Infect Dis. 2001 Dec 15;184(12):1608-12. doi: 10.1086/324580. Epub 2001 Dec 3. J Infect Dis. 2001. PMID: 11740738

4

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, Bamberger JD, Chesney MA, Moss A. Bangsberg DR, et al. Among authors: chesney ma. AIDS. 2000 Mar 10;14(4):357-66. doi: 10.1097/00002030-200003100-00008. AIDS. 2000. PMID: 10770537

5

Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.

Kahn JO, Martin JN, Roland ME, Bamberger JD, Chesney M, Chambers D, Franses K, Coates TJ, Katz MH. Kahn JO, et al. Among authors: chesney m. J Infect Dis. 2001 Mar 1;183(5):707-14. doi: 10.1086/318829. Epub 2001 Feb 1. J Infect Dis. 2001. PMID: 11181146

6

Seroconversion following nonoccupational postexposure prophylaxis against HIV.

Roland ME, Neilands TB, Krone MR, Katz MH, Franses K, Grant RM, Busch MP, Hecht FM, Shacklett BL, Kahn JO, Bamberger JD, Coates TJ, Chesney MA, Martin JN. Roland ME, et al. Among authors: chesney ma. Clin Infect Dis. 2005 Nov 15;41(10):1507-13. doi: 10.1086/497268. Epub 2005 Oct 13. Clin Infect Dis. 2005. PMID: 16231265 Clinical Trial.

7

Factors affecting adherence to antiretroviral therapy.

Chesney MA. Chesney MA. Clin Infect Dis. 2000 Jun;30 Suppl 2:S171-6. doi: 10.1086/313849. Clin Infect Dis. 2000. PMID: 10860902 Review.

8

Adherence to HIV combination therapy.

Chesney MA, Morin M, Sherr L. Chesney MA, et al. Soc Sci Med. 2000 Jun;50(11):1599-605. doi: 10.1016/s0277-9536(99)00468-2. Soc Sci Med. 2000. PMID: 10795966 Review.

9

Smokeless tobacco cessation intervention for college athletes: results after 1 year.

Walsh MM, Hilton JF, Masouredis CM, Gee L, Chesney MA, Ernster VL. Walsh MM, et al. Among authors: chesney ma. Am J Public Health. 1999 Feb;89(2):228-34. doi: 10.2105/ajph.89.2.228. Am J Public Health. 1999. PMID: 9949754 Free PMC article. Clinical Trial.

10

Adherence: a necessity for successful HIV combination therapy.

Chesney MA, Ickovics J, Hecht FM, Sikipa G, Rabkin J. Chesney MA, et al. AIDS. 1999;13 Suppl A:S271-8. AIDS. 1999. PMID: 10885784 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

344 results

Search Page

Filters